The Senate Wednesday invoked cloture and then passed by voice vote and sent to the President H.R.6331, legislation that includes suspension of the Medicare DME competitive bidding program, a 14-day reimbursement cycle for Medicare Part D claims, and a further delay in AMP-based Medicaid generic drug reimbursement cuts.
The cloture vote was 69 to 30. Sixty votes were required to move to final passage of the measure, whose main focus has been on preventing a 10.6 percent cut in Medicare payments to physicians. Two previous attempts failed in the Senate last month. The House passed the bill 355-59.
More details will be coming soon on what you can do ensure that the three vital community pharmacy provisions become law in the face of a predicted presidential veto.
Stay tuned!
Bill Popomaronis, R.Ph., NCPA vice president, home health and long term care pharmacy services, provides his thoughts and explanations on the latest DME information from CMS.
